Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
Apply
ACT-IOP-003
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step